Registrar Corp Registrar Corp LinkedIn Registrar Corp Twitter Registrar Corp Facebook Registrar Corp Google+ Registrar Corp Youtube Channel Registrar Corp FDA News Blog
HomeDrugsU.S. FDA Active Pharmaceutical Ingredients (API)API Examples › U.S. FDA Regulations: Etoposide Phosphate

U.S. FDA Requirements: Etoposide Phosphate

Pharmaceutical / Drug Definition : Damages DNA before mitosis by inhibiting topoisomerase II enzyme. This action impairs DNA synthesis and inhibits selected cancer cell growth. Cell-cycle-phase specific.

Registrar Corp assists Etoposide Phosphate companies with:

  • FDA Registration Etoposide Phosphate
  • FDA Listing Etoposide Phosphate
  • FDA Label Requirements and Exceptions Etoposide Phosphate
  • FDA Import Information Etoposide Phosphate
  • FDA Detentions Etoposide Phosphate (Etoposide Phosphate Entry Refusal)
  • General U.S. Food and Drug Administration Guidelines for:
       - Manufacturers Etoposide Phosphate (Etoposide Phosphate Suppliers)
       - Processors Etoposide Phosphate
       - Repackers Etoposide Phosphate
       - Relabelers Etoposide Phosphate
       - Exporters Etoposide Phosphate
       - Importers Etoposide Phosphate
For more information about Etoposide Phosphate, simply click below:




Live Help

 
U.S. FDA Regulations:

U.S. FDA Regulation: 21 C.F.R. Part 207


Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
Home | About Us | News | Resources | Exhibitions | Seminars | Associations | Careers | Sitemap | Terms of Use © 2014 Registrar Corp
 
Food and Beverages | Drugs | Cosmetics | Medical Devices | Radiation-Emitting Electronic Devices | Color Additives | Tobacco